Lupin receives UK MHRA Approval of Lutio for treatment of COPD

Lutio has the potential to offer significant cost savings when available to UK patients.

Granules India received ANDA approval for Guaifenesin and Pseudoephedrine Hydrochloride ER

Granules now have a total of 51 ANDA approvals from US FDA (49 Final approvals and 2 tentative approvals).

Sandu Pharmaceuticals launches Sandu Kumarvin

Sandu Kumarvin is an Ayurvedic digestive and immunity booster for children and also offers several other benefits.

Strong execution in Q2 drives full-year 2022 guidance upgrade for Sanofi

Apollo Hospitals Navi Mumbai performs first minimally invasive mitral heart valve replacement

Transcatheter Mitral valve procedure allows intervention on patients who are unsuitable or high risk for open heart surgery

Bayer posts higher sales, profit in first quarter

Company's net income rose by 57.5 percent to 3.291 billion euros in Q1

Intravacc signs an exclusive license agreement with Zhifei Lvzhu Biopharmaceutical

Avacc 3 has significant advantages over existing whooping cough vaccines

Sanofi continues to deliver strong business

Business EPS of €1.94, up 20.5% on a reported basis and 16.1% at CER, also benefitting from an improved effective tax rate

Doctors at Yashoda successfully treated advanced-stage laryngeal cancer

Deputy Mayor from Addis Ababa (Ethiopia) battled out a rare laryngeal cancer at Yashoda Hospitals Hyderabad

Bronchoscopic Thermal Vapor Ablation (BTVA): A new ray of hope for COPD patients

Yashoda Hospitals Hyderabad has earned the distinction of becoming the first to introduce BTVA in India